[(18)F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation

There is limited evidence regarding the application of [(18)F] fluorodeoxyglucose (FDG)-PET/MRI in patients with a suspected clinical recurrence, who underwent liver transplantation for hepatocellular carcinoma (HCC). Therefore, we compared the accuracy of PET/MR and standard-of-care (SOC) imaging i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zucchetta, Pietro, Lacognata, Carmelo, Girardi, Francesca, Spimpolo, Alessandro, Crimì, Filippo, Cabrelle, Giulio, Zanon, Chiara, Boccagni, Patrizia, Evangelista, Laura, Cecchin, Diego, Cillo, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897275/
https://www.ncbi.nlm.nih.gov/pubmed/35019883
http://dx.doi.org/10.1097/MNM.0000000000001518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897275/
https://www.ncbi.nlm.nih.gov/pubmed/35019883
http://dx.doi.org/10.1097/MNM.0000000000001518

Ejemplares similares